ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï
‰ïˆõƒƒOƒCƒ“ ‘ã•\ˆ¥ŽA
‘‰ïEŠwpW‰ï
‹³ˆçŠˆ“®Ü
Šw‰ïŽ
’芼
Κ
—˜‰v‘Š”½
–ðˆõ\¬
Ž––±‹ÇˆÄ“à
‹lŽ{݈ꗗ
ŠÖ˜AƒŠƒ“ƒN

@ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‰ïŽ ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹

<< Šw‰ïނ֖߂é
<< ‘O‚̃y[ƒW‚Ö–ß‚é

y“ÁWz
ƒƒ\ƒgƒŒƒLƒZ[ƒg“Š—^’†‚ÉStevens-JohnsonÇŒóŒQ‚ð’æ‚µ‚½“]ˆÚ«EN“üŠï‘ق̈ê—á


—±—ˆ@‘ñ, ²“¡@”ü‹IŽq, “Þ—Ç@ˆŸ‹MŽq, ¡ˆä@ˆêÍ, –Ø@–Î, •‹@–ƒ‹I, ˆÀ“¡@‹IŽq, ‚ˆÀ@‹`O, –Γc@”Žs
‰¡•lŽs—§Žs–¯•a‰@ŽY•wl‰È


Key wordsFGestational trophoblastic disease, Stevens-Johnson syndrome, Methotrexate

“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ïŽ, 47(4) 459-463, 2010


ˆê”ÊŽÐ’c–@lŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ïŽ––±‹Ç@§102-0083 “Œ‹ž“sç‘ã“c‹æ’¬4-7-7 ’¬ƒp[ƒNƒTƒCƒhƒrƒ‹402 Š”)MAƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒRƒ“ƒTƒ‹ƒeƒBƒ“ƒO“à
TELF03-3288-0993@FAXF03-5275-1192@E-mailFkantorengo@jsog-k.jp
Copyright (C) ˆê”ÊŽÐ’c–@lŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï